BR9801335B1 - composições farmacêuticas sob forma de comprimidos efervescentes contendo um princìpio ativo instável na presença de água. - Google Patents

composições farmacêuticas sob forma de comprimidos efervescentes contendo um princìpio ativo instável na presença de água.

Info

Publication number
BR9801335B1
BR9801335B1 BRPI9801335-1A BR9801335A BR9801335B1 BR 9801335 B1 BR9801335 B1 BR 9801335B1 BR 9801335 A BR9801335 A BR 9801335A BR 9801335 B1 BR9801335 B1 BR 9801335B1
Authority
BR
Brazil
Prior art keywords
active ingredient
water
pharmaceutical compositions
compositions containing
effervescent tablet
Prior art date
Application number
BRPI9801335-1A
Other languages
English (en)
Other versions
BR9801335A (pt
Inventor
Paolo Chiesi
Rosa Mezzadri
Gaetano Brambilla
Daniela Acerbi
Paolo Ventura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9801335A publication Critical patent/BR9801335A/pt
Publication of BR9801335B1 publication Critical patent/BR9801335B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI9801335-1A 1997-07-23 1998-03-10 composições farmacêuticas sob forma de comprimidos efervescentes contendo um princìpio ativo instável na presença de água. BR9801335B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001746A IT1293764B1 (it) 1997-07-23 1997-07-23 Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Publications (2)

Publication Number Publication Date
BR9801335A BR9801335A (pt) 1999-05-04
BR9801335B1 true BR9801335B1 (pt) 2010-09-21

Family

ID=11377613

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9801335-1A BR9801335B1 (pt) 1997-07-23 1998-03-10 composições farmacêuticas sob forma de comprimidos efervescentes contendo um princìpio ativo instável na presença de água.

Country Status (27)

Country Link
US (1) US6284272B1 (pt)
EP (1) EP1003486B1 (pt)
JP (1) JP4801255B2 (pt)
KR (1) KR100528141B1 (pt)
CN (1) CN1138535C (pt)
AT (1) ATE232092T1 (pt)
AU (1) AU743186B2 (pt)
BG (1) BG64074B1 (pt)
BR (1) BR9801335B1 (pt)
CZ (1) CZ296221B6 (pt)
DE (1) DE69811236T2 (pt)
DK (1) DK1003486T3 (pt)
EA (1) EA002608B1 (pt)
ES (1) ES2191960T3 (pt)
HK (1) HK1029525A1 (pt)
HU (1) HU226115B1 (pt)
IL (1) IL134166A (pt)
IT (1) IT1293764B1 (pt)
NO (1) NO326639B1 (pt)
NZ (1) NZ502479A (pt)
OA (1) OA10999A (pt)
PL (1) PL199164B1 (pt)
PT (1) PT1003486E (pt)
SI (1) SI1003486T1 (pt)
SK (1) SK284551B6 (pt)
TR (1) TR199900675T1 (pt)
WO (1) WO1999004765A2 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
US6956029B1 (en) * 1999-07-02 2005-10-18 Sca Lohnherstellungs Ag Solid formulation of glucosamine sulphate
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
IN190018B (pt) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
JP2004506680A (ja) * 2000-08-18 2004-03-04 ファルマシア・コーポレーション シクロオキシゲナーゼ−２阻害剤の迅速崩壊経口製剤
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
US20030091627A1 (en) * 2001-10-31 2003-05-15 Vinay Sharma Rate-controlled delivery of macrolides
KR100456273B1 (ko) 2001-11-16 2004-11-10 김용년 산과 반응하여 일정 속도로 이산화탄소를 발생시킬 수있는 고상 제제 및 그의 제조 방법
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
ATE541575T1 (de) 2002-03-06 2012-02-15 Effrx Pharmaceuticals Sa Brausetabletten, enthaltend alendronat
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
CN100445263C (zh) * 2003-04-24 2008-12-24 四川大学 甘氨酸钠碳酸盐的微波合成方法
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
PL2260871T3 (pl) 2004-04-01 2013-10-31 Pf Medicament Kompleksy inkluzyjne zawierające piroksykam, cyklodekstrynę i argininę
AU2005247048B2 (en) * 2004-05-28 2007-12-13 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP1901720A2 (en) * 2005-06-23 2008-03-26 Spherics, Inc. Improved dosage forms for movement disorder treatment
CN100341488C (zh) * 2005-11-22 2007-10-10 瑞普（保定）生物药业有限公司 一种饮水免疫泡腾片及其制备方法
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
WO2008079404A2 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
WO2008140772A2 (en) * 2007-05-08 2008-11-20 Hercules Incorporated Robust rapid disintegration tablet formulation
CA2711014C (en) 2007-12-28 2018-10-23 Impax Laboratories, Inc. Controlled release formulations of levodopa and uses thereof
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
BRPI0916344A2 (pt) 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
WO2011114239A2 (en) * 2010-03-13 2011-09-22 Eastpond Laboratories Limited Fat-binding compositions
CN101836951B (zh) * 2010-05-20 2013-06-05 山东达因海洋生物制药股份有限公司 一种含盐酸氨溴索的口服溶液及其制备方法
CN102322123B (zh) * 2011-06-30 2013-09-18 德清艺玛工艺装饰有限公司 一种仿大理石泡沫装饰材料
CN102398378A (zh) * 2011-11-03 2012-04-04 北京华禧联合科技发展有限公司 镀铬冲模在硫酸氢氯吡格雷片制备过程中的应用
CA2894272A1 (en) * 2012-12-14 2014-06-19 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
CA2926082C (en) 2013-10-07 2022-06-14 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP2870961B1 (en) * 2013-11-06 2018-07-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of pramipexole
EP3758754A1 (en) 2018-03-02 2021-01-06 Chiesi Farmaceutici S.p.A. A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
ATE76747T1 (de) * 1986-06-10 1992-06-15 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
CH675537A5 (pt) * 1988-03-25 1990-10-15 Ciba Geigy Ag
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
ATE108649T1 (de) * 1990-02-14 1994-08-15 Takeda Chemical Industries Ltd Brausemischung, deren herstellung sowie verwendung.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
JP2910425B2 (ja) * 1992-06-17 1999-06-23 和光純薬工業株式会社 発泡性錠剤の新規な製造方法
JP3170139B2 (ja) * 1994-04-08 2001-05-28 エスエス製薬株式会社 発泡性錠剤
FR2733420B1 (fr) * 1995-04-28 1997-06-27 Sep Tarral Preparations pectiques utilisables comme support de medicament
DE69726879T2 (de) * 1996-05-17 2004-10-14 Merck & Co., Inc. Biphosphonat-formulierung mit brausewirkung

Also Published As

Publication number Publication date
DE69811236T2 (de) 2003-10-30
SK922000A3 (en) 2000-07-11
BG64074B1 (bg) 2003-12-31
HK1029525A1 (en) 2001-04-06
PL338502A1 (en) 2000-11-06
KR20010022140A (ko) 2001-03-15
HUP0003897A3 (en) 2006-06-28
OA10999A (en) 2001-11-07
US6284272B1 (en) 2001-09-04
ATE232092T1 (de) 2003-02-15
IL134166A (en) 2005-08-31
DK1003486T3 (da) 2003-05-19
BR9801335A (pt) 1999-05-04
WO1999004765A3 (en) 1999-06-10
PT1003486E (pt) 2003-06-30
KR100528141B1 (ko) 2005-11-15
BG103253A (en) 1999-09-30
HUP0003897A2 (hu) 2001-08-28
AU8977798A (en) 1999-02-16
SI1003486T1 (en) 2003-08-31
PL199164B1 (pl) 2008-08-29
EP1003486A2 (en) 2000-05-31
CZ296221B6 (cs) 2006-02-15
JP4801255B2 (ja) 2011-10-26
EA200000062A1 (ru) 2000-10-30
ITMI971746A1 (it) 1999-01-23
CZ2000255A3 (cs) 2000-07-12
NO991376L (no) 1999-05-25
TR199900675T1 (xx) 1999-11-22
EP1003486B1 (en) 2003-02-05
ES2191960T3 (es) 2003-09-16
AU743186B2 (en) 2002-01-17
CN1138535C (zh) 2004-02-18
NO326639B1 (no) 2009-01-26
IT1293764B1 (it) 1999-03-10
EA002608B1 (ru) 2002-06-27
CN1267215A (zh) 2000-09-20
WO1999004765A2 (en) 1999-02-04
NZ502479A (en) 2002-02-01
JP2001510789A (ja) 2001-08-07
HU226115B1 (en) 2008-04-28
NO991376D0 (no) 1999-03-22
DE69811236D1 (de) 2003-03-13
SK284551B6 (sk) 2005-06-02
IL134166A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
BR9801335B1 (pt) composições farmacêuticas sob forma de comprimidos efervescentes contendo um princìpio ativo instável na presença de água.
DE69626117D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
AR018829A1 (es) Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos
ATE495154T1 (de) Pharmazeutische zusammensetzungen, die ccr5- antagonisierende piperazinderivate enthalten
ES2110212T3 (es) Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion.
HUP0300195A3 (en) Heterocyclic sodium/proton exchange inhibitors and pharmaceutical compositions containing them
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
BR0113070A (pt) Composições farmacêuticas contendo carbonato de lìtio
CA2297673A1 (en) Pharmaceutical compositions containing an effervescent acid-base couple
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
CA2225628A1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/09/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2307 DE 24-03-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.